PFIZER INC Deferred Tax Liabilities, Net, Noncurrent
PFIZER INC (PFE) had Deferred Tax Liabilities, Net, Noncurrent of $30.75 billion as of 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesNoncurrent · last filed 2017-02-23
- 2016-12-31: Deferred Tax Liabilities, Net, Noncurrent $30.75B.
- 2016-10-02: Deferred Tax Liabilities, Net, Noncurrent $31.69B.
- 2016-07-03: Deferred Tax Liabilities, Net, Noncurrent $28.30B.
- 2016-04-03: Deferred Tax Liabilities, Net, Noncurrent $26.55B.
| Period end | Deferred Tax Liabilities, Net, Noncurrent | Deferred Tax Liabilities, Net, Noncurrent as first filed |
|---|---|---|
| 2016-12-31 | $30.75B 10-K · filed 2017-02-23 | |
| 2016-10-02 | $31.69B 10-Q · filed 2016-11-10 | |
| 2016-07-03 | $28.30B 10-Q · filed 2016-08-11 | |
| 2016-04-03 | $26.55B 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $26.88B 10-K · filed 2017-02-23 | |
| 2015-09-27 | $28.65B 10-Q · filed 2015-11-05 | |
| 2015-06-28 | $24.66B 10-Q · filed 2015-08-06 | |
| 2015-03-29 | $24.47B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $23.32B 10-K · filed 2016-02-29 | $24.98B 10-K · filed 2015-02-27 |
| 2014-09-28 | $26.32B 10-Q · filed 2014-11-06 | |
| 2014-06-29 | $26.31B 10-Q · filed 2014-08-07 | |
| 2014-03-30 | $25.92B 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $25.59B 10-K · filed 2015-02-27 | |
| 2013-09-29 | $22.43B 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $22.34B 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $22.45B 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $21.19B 10-K · filed 2014-02-28 | $21.59B 10-K · filed 2013-02-28 |
| 2012-09-30 | $19.13B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $18.49B 10-Q · filed 2012-08-09 | |
| 2012-04-01 | $19.74B 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $18.86B 10-K · filed 2013-02-28 | $19.60B 10-K · filed 2012-02-28 |
| 2011-10-02 | $20.41B 10-Q · filed 2011-11-10 | |
| 2011-07-03 | $20.07B 10-Q · filed 2011-08-11 | |
| 2011-04-03 | $19.41B 10-Q · filed 2011-05-12 | |
| 2010-12-31 | $18.63B 10-K · filed 2012-02-28 | $18.65B 10-K · filed 2011-02-28 |
| 2010-10-03 | $16.94B 10-Q · filed 2010-11-12 | |
| 2010-07-04 | $17.34B 10-Q · filed 2010-08-12 | |
| 2010-04-04 | $17.46B 10-Q · filed 2010-05-13 | |
| 2009-12-31 | $17.84B 10-K · filed 2011-02-28 | |
| 2009-09-27 | $2.42B 10-Q · filed 2009-11-05 | |
| 2009-06-28 | $2.36B 10-Q · filed 2009-08-06 | |
| 2008-12-31 | $2.96B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |